Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Ndel1 oligopeptidase activity as a potential biomarker of early stages of schizophrenia.

Dal Mas C, Nani JV, Noto C, Yonamine CM, da Cunha GR, Mansur RB, Ota VK, Belangero SI, Cordeiro Q, Kapczinski F, Brietzke E, Bressan RA, Gadelha A, Hayashi MAF.

Schizophr Res. 2019 Mar 8. pii: S0920-9964(19)30081-7. doi: 10.1016/j.schres.2019.02.021. [Epub ahead of print]

PMID:
30857875
2.

Effects of the interaction between genetic factors and maltreatment on child and adolescent psychiatric disorders.

Carvalho CM, Pan PM, Ota VK, Spindola LM, Xavier G, Santoro ML, Mazzotti DR, Pellegrino R, Hakonarson H, Rohde LA, Miguel EC, Gadelha A, Bressan RA, Belangero SI.

Psychiatry Res. 2019 Jan 29;273:575-577. doi: 10.1016/j.psychres.2019.01.078. [Epub ahead of print]

PMID:
30716596
3.

Activation of the immune-inflammatory response system and the compensatory immune-regulatory system in antipsychotic naive first episode psychosis.

Noto MN, Maes M, Nunes SOV, Ota VK, Rossaneis AC, Verri WA Jr, Cordeiro Q, Belangero SI, Gadelha A, Bressan RA, Noto C.

Eur Neuropsychopharmacol. 2019 Mar;29(3):416-431. doi: 10.1016/j.euroneuro.2018.12.008. Epub 2018 Dec 26.

PMID:
30594344
4.

Effect of male-specific childhood trauma on telomere length.

Xavier G, Spindola LM, Ota VK, Carvalho CM, Maurya PK, Tempaku PF, Moretti PN, Mazotti DR, Sato JR, Brietzke E, Miguel EC, Grassi-Oliveira R, Mari J, Bressan RA, Gadelha A, Pan PM, Belangero SI.

J Psychiatr Res. 2018 Dec;107:104-109. doi: 10.1016/j.jpsychires.2018.10.012. Epub 2018 Oct 22.

PMID:
30384090
5.

Applying polygenic risk scoring for psychiatric disorders to a large family with bipolar disorder and major depressive disorder.

de Jong S, Diniz MJA, Saloma A, Gadelha A, Santoro ML, Ota VK, Noto C; Major Depressive Disorder and Bipolar Disorder Working Groups of the Psychiatric Genomics Consortium, Curtis C, Newhouse SJ, Patel H, Hall LS, O Reilly PF, Belangero SI, Bressan RA, Breen G.

Commun Biol. 2018 Oct 8;1:163. doi: 10.1038/s42003-018-0155-y. eCollection 2018.

6.

Polygenic risk score analyses of symptoms and treatment response in an antipsychotic-naive first episode of psychosis cohort.

Santoro ML, Ota V, de Jong S, Noto C, Spindola LM, Talarico F, Gouvea E, Lee SH, Moretti P, Curtis C, Patel H, Newhouse S, Carvalho CM, Gadelha A, Cordeiro Q, Bressan RA, Belangero SI, Breen G.

Transl Psychiatry. 2018 Aug 31;8(1):174. doi: 10.1038/s41398-018-0230-7.

7.

Investigating brain structural patterns in first episode psychosis and schizophrenia using MRI and a machine learning approach.

de Moura AM, Pinaya WHL, Gadelha A, Zugman A, Noto C, Cordeiro Q, Belangero SI, Jackowski AP, Bressan RA, Sato JR.

Psychiatry Res Neuroimaging. 2018 May 30;275:14-20. doi: 10.1016/j.pscychresns.2018.03.003. Epub 2018 Mar 6.

PMID:
29548527
8.

Effects of the brain-derived neurotropic factor variant Val66Met on cortical structure in late childhood and early adolescence.

de Araujo CM, Zugman A, Swardfager W, Belangero SIN, Ota VK, Spindola LM, Hakonarson H, Pellegrino R, Gadelha A, Salum GA, Pan PM, de Moura LM, Del Aquilla M, Picon FA, Amaro E Jr, Sato JR, Brietzke E, Grassi-Oliveira R, Rohde LAP, Miguel EC, Bressan RA, Jackowski AP.

J Psychiatr Res. 2018 Mar;98:51-58. doi: 10.1016/j.jpsychires.2017.12.008. Epub 2017 Dec 20.

PMID:
29288952
9.

Leukocyte telomere length variation in different stages of schizophrenia.

Maurya PK, Rizzo LB, Xavier G, Tempaku PF, Ota VK, Santoro ML, Spíndola LM, Moretti PS, Mazzotti DR, Gadelha A, Gouvea ES, Noto C, Maes M, Cordeiro Q, Bressan RA, Brietzke E, Belangero SI.

J Psychiatr Res. 2018 Jan;96:218-223. doi: 10.1016/j.jpsychires.2017.10.016. Epub 2017 Oct 21.

PMID:
29102816
10.

Single-nucleotide polymorphisms in genes related to the hypothalamic-pituitary-adrenal axis as risk factors for posttraumatic stress disorder.

Carvalho CM, Coimbra BM, Ota VK, Mello MF, Belangero SI.

Am J Med Genet B Neuropsychiatr Genet. 2017 Oct;174(7):671-682. doi: 10.1002/ajmg.b.32564. Epub 2017 Jul 7. Review.

PMID:
28686326
11.

Stress-related telomere length in children: A systematic review.

Coimbra BM, Carvalho CM, Moretti PN, Mello MF, Belangero SI.

J Psychiatr Res. 2017 Sep;92:47-54. doi: 10.1016/j.jpsychires.2017.03.023. Epub 2017 Apr 2. Review.

PMID:
28407508
12.

Gene expression in blood of children and adolescents: Mediation between childhood maltreatment and major depressive disorder.

Spindola LM, Pan PM, Moretti PN, Ota VK, Santoro ML, Cogo-Moreira H, Gadelha A, Salum G, Manfro GG, Mari JJ, Brentani H, Grassi-Oliveira R, Brietzke E, Miguel EC, Rohde LA, Sato JR, Bressan RA, Belangero SI.

J Psychiatr Res. 2017 Sep;92:24-30. doi: 10.1016/j.jpsychires.2017.03.015. Epub 2017 Mar 22.

PMID:
28384542
13.

Shorter leukocyte telomere length in patients at ultra high risk for psychosis.

Maurya PK, Rizzo LB, Xavier G, Tempaku PF, Zeni-Graiff M, Santoro ML, Mazzotti DR, Zugman A, Pan P, Noto C, Maes M, Asevedo E, Mansur RB, Cunha GR, Gadelha A, Bressan RA, Belangero SI, Brietzke E.

Eur Neuropsychopharmacol. 2017 May;27(5):538-542. doi: 10.1016/j.euroneuro.2017.02.008. Epub 2017 Mar 6.

PMID:
28274506
14.

Catechol-O-methyltransferase (COMT) polymorphisms modulate working memory in individuals with schizophrenia and healthy controls.

Matsuzaka CT, Christofolini D, Ota VK, Gadelha A, Berberian AA, Noto C, Mazzotti DR, Spindola LM, Moretti PN, Smith MAC, Melaragno MI, Belangero SI, Bressan RA.

Braz J Psychiatry. 2017 Oct-Dec;39(4):302-308. doi: 10.1590/1516-4446-2016-1987. Epub 2017 Mar 2.

15.

The role of the CNR1 gene in schizophrenia: a systematic review including unpublished data.

Gouvêa ES, Santos AF Filho, Ota VK, Mrad V, Gadelha A, Bressan RA, Cordeiro Q, Belangero SI.

Braz J Psychiatry. 2017 Apr-Jun;39(2):160-171. doi: 10.1590/1516-4446-2016-1969. Epub 2017 Jan 12. Review.

16.

Perinatal complications, lipid peroxidation, and mental health problems in a large community pediatric sample.

Mansur RB, Cunha GR, Asevedo E, Zugman A, Rios AC, Salum GA, Pan PM, Gadelha A, Levandowski ML, Belangero SI, Manfro GG, Stertz L, Kauer-Sant'anna M, Miguel EC, Bressan RA, Mari JJ, Grassi-Oliveira R, Brietzke E.

Eur Child Adolesc Psychiatry. 2017 May;26(5):521-529. doi: 10.1007/s00787-016-0914-6. Epub 2016 Oct 26.

PMID:
27785581
17.

Gene expression alterations related to mania and psychosis in peripheral blood of patients with a first episode of psychosis.

Gouvea ES, Ota VK, Noto C, Santoro ML, Spindola LM, Moretti PN, Carvalho CM, Xavier G, Rios AC, Sato JR, Hayashi MA, Brietzke E, Gadelha A, Bressan RA, Cordeiro Q, Belangero SI.

Transl Psychiatry. 2016 Oct 4;6(10):e908. doi: 10.1038/tp.2016.159.

18.

The effect of the severity of obstructive sleep apnea syndrome on telomere length.

Tempaku PF, Mazzotti DR, Hirotsu C, Andersen ML, Xavier G, Maurya PK, Rizzo LB, Brietzke E, Belangero SI, Bittencourt L, Tufik S.

Oncotarget. 2016 Oct 25;7(43):69216-69224. doi: 10.18632/oncotarget.12293.

19.

Socioeconomic Disadvantage Moderates the Association between Peripheral Biomarkers and Childhood Psychopathology.

Mansur RB, Cunha GR, Asevedo E, Zugman A, Zeni-Graiff M, Rios AC, Sethi S, Maurya PK, Levandowski ML, Gadelha A, Pan PM, Stertz L, Belangero SI, Kauer-Sant' Anna M, Teixeira AL, Mari JJ, Rohde LA, Miguel EC, McIntyre RS, Grassi-Oliveira R, Bressan RA, Brietzke E.

PLoS One. 2016 Aug 4;11(8):e0160455. doi: 10.1371/journal.pone.0160455. eCollection 2016.

20.

A current snapshot of common genomic variants contribution in psychiatric disorders.

Santoro ML, Moretti PN, Pellegrino R, Gadelha A, Abílio VC, Hayashi MA, Belangero SI, Hakonarson H.

Am J Med Genet B Neuropsychiatr Genet. 2016 Dec;171(8):997-1005. doi: 10.1002/ajmg.b.32475. Epub 2016 Aug 3. Review.

PMID:
27486013
21.

Corrigendum: An integrative approach to investigate the respective roles of single-nucleotide variants and copy-number variants in Attention-Deficit/Hyperactivity Disorder.

Lima Lde A, Feio-Dos-Santos AC, Belangero SI, Gadelha A, Bressan RA, Salum GA, Pan PM, Moriyama TS, Graeff-Martins AS, Tamanaha AC, Alvarenga P, Krieger FV, Fleitlich-Bilyk B, Jackowski AP, Brietzke E, Sato JR, Polanczyk GV, Mari Jde J, Manfro GG, do Rosário MC, Miguel EC, Puga RD, Tahira AC, Souza VN, Chile T, Gouveia GR, Simões SN, Chang X, Pellegrino R, Tian L, Glessner JT, Hashimoto RF, Rohde LA, Sleiman PM, Hakonarson H, Brentani H.

Sci Rep. 2016 May 24;6:25861. doi: 10.1038/srep25861. No abstract available.

22.

An integrative approach to investigate the respective roles of single-nucleotide variants and copy-number variants in Attention-Deficit/Hyperactivity Disorder.

Lima Lde A, Feio-dos-Santos AC, Belangero SI, Gadelha A, Bressan RA, Salum GA, Pan PM, Moriyama TS, Graeff-Martins AS, Tamanaha AC, Alvarenga P, Krieger FV, Fleitlich-Bilyk B, Jackowski AP, Brietzke E, Sato JR, Polanczyk GV, Mari Jde J, Manfro GG, do Rosário MC, Miguel EC, Puga RD, Tahira AC, Souza VN, Chile T, Gouveia GR, Simões SN, Chang X, Pellegrino R, Tian L, Glessner JT, Hashimoto RF, Rohde LA, Sleiman PM, Hakonarson H, Brentani H.

Sci Rep. 2016 Mar 7;6:22851. doi: 10.1038/srep22851. Erratum in: Sci Rep. 2016 May 24;6:25861.

23.

Genome-wide investigation of schizophrenia associated plasma Ndel1 enzyme activity.

Gadelha A, Coleman J, Breen G, Mazzoti DR, Yonamine CM, Pellegrino R, Ota VK, Belangero SI, Glessner J, Sleiman P, Hakonarson H, Hayashi MA, Bressan RA.

Schizophr Res. 2016 Apr;172(1-3):60-7. doi: 10.1016/j.schres.2016.01.043. Epub 2016 Feb 2.

PMID:
26851141
24.

Hair cortisol in drug-naïve first-episode individuals with psychosis.

Andrade EH, Rizzo LB, Noto C, Ota VK, Gadelha A, Daruy-Filho L, Tasso Bde C, Mansur RB, Cordeiro Q, Belangero SI, Bressan RA, Grassi-Oliveira R, Brietzke E.

Braz J Psychiatry. 2016 Mar;38(1):11-6. doi: 10.1590/1516-4446-2014-1634. Epub 2016 Jan 26.

25.

Depression, Cytokine, and Cytokine by Treatment Interactions Modulate Gene Expression in Antipsychotic Naïve First Episode Psychosis.

Noto C, Ota VK, Santoro ML, Gouvea ES, Silva PN, Spindola LM, Cordeiro Q, Bressan RA, Gadelha A, Brietzke E, Belangero SI, Maes M.

Mol Neurobiol. 2016 Oct;53(8):5701-9. doi: 10.1007/s12035-015-9489-3. Epub 2015 Oct 22.

PMID:
26491028
26.

Increased expression of NDEL1 and MBP genes in the peripheral blood of antipsychotic-naïve patients with first-episode psychosis.

Ota VK, Noto C, Santoro ML, Spindola LM, Gouvea ES, Carvalho CM, Santos CM, Xavier G, Higuchi CH, Yonamine C, Moretti PN, Abílio VC, Hayashi MA, Brietzke E, Gadelha A, Cordeiro Q, Bressan RA, Belangero SI.

Eur Neuropsychopharmacol. 2015 Dec;25(12):2416-25. doi: 10.1016/j.euroneuro.2015.09.013. Epub 2015 Oct 9.

PMID:
26476704
27.

Structural covariance in schizophrenia and first-episode psychosis: An approach based on graph analysis.

Zugman A, Assunção I, Vieira G, Gadelha A, White TP, Oliveira PP, Noto C, Crossley N, Mcguire P, Cordeiro Q, Belangero SI, Bressan RA, Jackowski AP, Sato JR.

J Psychiatr Res. 2015 Dec;71:89-96. doi: 10.1016/j.jpsychires.2015.09.018. Epub 2015 Oct 22.

PMID:
26458012
28.

Early life adversity, genomic plasticity, and psychopathology.

Turecki G, Ota VK, Belangero SI, Jackowski A, Kaufman J.

Lancet Psychiatry. 2014 Nov;1(6):461-6. doi: 10.1016/S2215-0366(14)00022-4. Epub 2014 Nov 5. Review.

29.

Low expression of Gria1 and Grin1 glutamate receptors in the nucleus accumbens of Spontaneously Hypertensive Rats (SHR).

Diana MC, Santoro ML, Xavier G, Santos CM, Spindola LN, Moretti PN, Ota VK, Bressan RA, Abilio VC, Belangero SI.

Psychiatry Res. 2015 Oct 30;229(3):690-4. doi: 10.1016/j.psychres.2015.08.021. Epub 2015 Aug 12.

PMID:
26296755
30.

Oxidative stress in drug naïve first episode psychosis and antioxidant effects of risperidone.

Noto C, Ota VK, Gadelha A, Noto MN, Barbosa DS, Bonifácio KL, Nunes SO, Cordeiro Q, Belangero SI, Bressan RA, Maes M, Brietzke E.

J Psychiatr Res. 2015 Sep;68:210-6. doi: 10.1016/j.jpsychires.2015.07.003. Epub 2015 Jul 3.

PMID:
26228421
31.

Inflammation, neurotrophism and oxidative stress and childhood psychopathology in a large community sample.

Cunha GR, Asevedo E, Mansur RB, Zugman A, Pan PM, Gadelha A, Belangero SI, Rizzo LB, Coelho R, Stertz L, Cogo-Moreira H, Grassi-Oliveira R, Teixeira AL, Kauer-Sant'Anna M, Mari JJ, Miguel EC, Bressan RA, Brietzke E.

Acta Psychiatr Scand. 2016 Feb;133(2):122-132. doi: 10.1111/acps.12453. Epub 2015 Jul 3. Erratum in: Acta Psychiatr Scand. 2016 Dec;134(6):569-570.

PMID:
26139469
32.

Lowered paraoxonase 1 (PON1) activity is associated with increased cytokine levels in drug naïve first episode psychosis.

Brinholi FF, Noto C, Maes M, Bonifácio KL, Brietzke E, Ota VK, Gadelha A, Cordeiro Q, Belangero SI, Bressan RA, Vargas HO, Higachi L, de Farias CC, Moreira EG, Barbosa DS.

Schizophr Res. 2015 Aug;166(1-3):225-30. doi: 10.1016/j.schres.2015.06.009. Epub 2015 Jun 27.

PMID:
26123170
33.

Gene expression analysis in blood of ultra-high risk subjects compared to first-episode of psychosis patients and controls.

Santoro ML, Gadelha A, Ota VK, Cunha GR, Asevedo E, Noto CS, Spindola LM, Pan PM, Talarico F, Mansur RB, Silva PN, Brietzke E, Cordeiro Q, Bressan RA, Belangero SI.

World J Biol Psychiatry. 2015 Sep;16(6):441-446. doi: 10.3109/15622975.2015.1048724. Epub 2015 Jun 18.

PMID:
26089098
34.

Effects of depression on the cytokine profile in drug naïve first-episode psychosis.

Noto C, Ota VK, Santoro ML, Ortiz BB, Rizzo LB, Higuchi CH, Cordeiro Q, Belangero SI, Bressan RA, Gadelha A, Maes M, Brietzke E.

Schizophr Res. 2015 May;164(1-3):53-8. doi: 10.1016/j.schres.2015.01.026. Epub 2015 Feb 21.

PMID:
25716958
35.

ACE I/D genotype-related increase in ACE plasma activity is a better predictor for schizophrenia diagnosis than the genotype alone.

Gadelha A, Yonamine CM, Ota VK, Oliveira V, Sato JR, Belangero SI, Bressan RA, Hayashi MA.

Schizophr Res. 2015 May;164(1-3):109-14. doi: 10.1016/j.schres.2015.01.044. Epub 2015 Feb 17.

PMID:
25701466
36.

Effects of risperidone on cytokine profile in drug-naïve first-episode psychosis.

Noto C, Ota VK, Gouvea ES, Rizzo LB, Spindola LM, Honda PH, Cordeiro Q, Belangero SI, Bressan RA, Gadelha A, Maes M, Brietzke E.

Int J Neuropsychopharmacol. 2014 Oct 31;18(4). pii: pyu042. doi: 10.1093/ijnp/pyu042.

37.

Changes in gene expression and methylation in the blood of patients with first-episode psychosis.

Ota VK, Noto C, Gadelha A, Santoro ML, Spindola LM, Gouvea ES, Stilhano RS, Ortiz BB, Silva PN, Sato JR, Han SW, Cordeiro Q, Bressan RA, Belangero SI.

Schizophr Res. 2014 Nov;159(2-3):358-64. doi: 10.1016/j.schres.2014.09.008. Epub 2014 Sep 28.

PMID:
25270546
38.

Identification of suitable reference genes for gene expression studies of shoulder instability.

Leal MF, Belangero PS, Cohen C, Figueiredo EA, Loyola LC, Pochini AC, Smith MC, Andreoli CV, Belangero SI, Ejnisman B, Cohen M.

PLoS One. 2014 Aug 14;9(8):e105002. doi: 10.1371/journal.pone.0105002. eCollection 2014.

39.

Gene expression analysis in patients with traumatic anterior shoulder instability suggests deregulation of collagen genes.

Belangero PS, Leal MF, Figueiredo EA, Cohen C, Pochini Ade C, Smith MC, Andreoli CV, Belangero SI, Ejnisman B, Cohen M.

J Orthop Res. 2014 Oct;32(10):1311-6. doi: 10.1002/jor.22680. Epub 2014 Jul 11.

40.

Expression profile of neurotransmitter receptor and regulatory genes in the prefrontal cortex of spontaneously hypertensive rats: relevance to neuropsychiatric disorders.

Santoro ML, Santos CM, Ota VK, Gadelha A, Stilhano RS, Diana MC, Silva PN, Spíndola LM, Melaragno MI, Bressan RA, Han SW, Abílio VC, Belangero SI.

Psychiatry Res. 2014 Nov 30;219(3):674-9. doi: 10.1016/j.psychres.2014.05.034. Epub 2014 Jun 5.

PMID:
25041985
41.

Factor structure of the Positive and Negative Syndrome Scale (PANSS) in Brazil: convergent validation of the Brazilian version.

Higuchi CH, Ortiz B, Berberian AA, Noto C, Cordeiro Q, Belangero SI, Pitta JC, Gadelha A, Bressan RA.

Braz J Psychiatry. 2014 Oct-Dec;36(4):336-9. doi: 10.1590/1516-4446-2013-1330. Epub 2014 Jul 16.

42.

Evaluation of neurotransmitter receptor gene expression identifies GABA receptor changes: a follow-up study in antipsychotic-naïve patients with first-episode psychosis.

Ota VK, Noto C, Gadelha A, Santoro ML, Ortiz BB, Andrade EH, Tasso BC, Spindola LM, Silva PN, Abílio VC, Smith Mde A, Sato JR, Brietzke E, Cordeiro Q, Bressan RA, Belangero SI.

J Psychiatr Res. 2014 Sep;56:130-6. doi: 10.1016/j.jpsychires.2014.05.012. Epub 2014 Jun 4.

PMID:
24935901
43.

Effect of antipsychotic drugs on gene expression in the prefrontal cortex and nucleus accumbens in the spontaneously hypertensive rat (SHR).

Santoro ML, Ota VK, Stilhano RS, Silva PN, Santos CM, Diana MC, Gadelha A, Bressan RA, Melaragno MI, Han SW, Abílio VC, Belangero SI.

Schizophr Res. 2014 Aug;157(1-3):163-8. doi: 10.1016/j.schres.2014.05.015. Epub 2014 Jun 2.

PMID:
24893910
44.

The theory of bipolar disorder as an illness of accelerated aging: implications for clinical care and research.

Rizzo LB, Costa LG, Mansur RB, Swardfager W, Belangero SI, Grassi-Oliveira R, McIntyre RS, Bauer ME, Brietzke E.

Neurosci Biobehav Rev. 2014 May;42:157-69. doi: 10.1016/j.neubiorev.2014.02.004. Epub 2014 Feb 15. Review.

PMID:
24548785
45.

PRODH polymorphisms, cortical volumes and thickness in schizophrenia.

Ota VK, Bellucco FT, Gadelha A, Santoro ML, Noto C, Christofolini DM, Assunção IB, Yamada KM, Ribeiro-dos-Santos AK, Santos S, Mari JJ, Smith MA, Melaragno MI, Bressan RA, Sato JR, Jackowski AP, Belangero SI.

PLoS One. 2014 Feb 3;9(2):e87686. doi: 10.1371/journal.pone.0087686. eCollection 2014.

46.

Comparing PANSS scores and corresponding CGI scores between stable and acute schizophrenic patients.

Ortiz BB, Pitta JC, Gadelha A, Mattos NF, Cunha JY, de Araújo Filho GM, Cordeiro Q, Belangero SI, Bressan RA.

Schizophr Res. 2014 Jan;152(1):307-8. doi: 10.1016/j.schres.2013.11.016. Epub 2013 Dec 4. No abstract available.

PMID:
24314668
47.

Neurotransmitter receptor and regulatory gene expression in peripheral blood of Brazilian drug-naïve first-episode psychosis patients before and after antipsychotic treatment.

Ota VK, Noto C, Gadelha A, Santoro ML, Silva PN, Melaragno MI, Smith Mde A, Cordeiro Q, Bressan RA, Belangero SI.

Psychiatry Res. 2013 Dec 30;210(3):1290-2. doi: 10.1016/j.psychres.2013.09.016. Epub 2013 Oct 7.

PMID:
24113126
48.

Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia.

Asevedo E, Gadelha A, Noto C, Mansur RB, Zugman A, Belangero SI, Berberian AA, Scarpato BS, Leclerc E, Teixeira AL, Gama CS, Bressan RA, Brietzke E.

J Psychiatr Res. 2013 Oct;47(10):1376-82. doi: 10.1016/j.jpsychires.2013.05.032. Epub 2013 Jun 25.

PMID:
23806580
49.

Is there an association between cortical thickness, age of onset, and duration of illness in schizophrenia?

Assunção Leme IB, Gadelha A, Sato JR, Ota VK, Mari JJ, Melaragno MI, Smith MA, Belangero SI, Bressan RA, Jackowski AP.

CNS Spectr. 2013 Dec;18(6):315-21. doi: 10.1017/S1092852913000333. Epub 2013 Jun 6.

PMID:
23739259
50.

Reduced dorso-lateral prefrontal cortex in treatment resistant schizophrenia.

Zugman A, Gadelha A, Assunção I, Sato J, Ota VK, Rocha DL, Mari JJ, Belangero SI, Bressan RA, Brietzke E, Jackowski AP.

Schizophr Res. 2013 Aug;148(1-3):81-6. doi: 10.1016/j.schres.2013.05.002. Epub 2013 May 28.

PMID:
23721966

Supplemental Content

Loading ...
Support Center